Background
Gallbladder cancer (GBC) is the most common type of biliary tract cancer (BTC), which has a high mortality and a poor prognosis [
1‐
4]. According to the 8th American Joint Committee on Cancer (AJCC) guideline [
5], surgical resection is the best potential treatment for GBC at an early stage, while chemotherapy/radiotherapy/immunotherapy/targeted therapy is recommended for GBC at an advanced stage. Patients with advanced GBC have limited response to treatment and poor prognosis due to the highly invasive and metastatic characteristics of GBC, including local tumor growth, hepatic invasion, and lymph nodes metastasis [
6,
7]. Several studies reported the crucial role of multiple biological processes in cancer invasion and metastasis, such as circulating cancer cells, immune evasion [
8], epithelial-mesenchymal transition (EMT) [
9,
10], and cancer stem cells [
11], while the multi-step process and the molecular mechanism of GBC remained unclear. Therefore, it is urgent to explore the novel biomarkers associated with invasion and metastasis in GBC patients to improve the prognosis.
MiRNAs, the small single-stranded non-coding RNAs (ranging from 18 to 25 bp in length), are critical in tumor development, such as invasion, migration, and metastasis [
12,
13]. Different expression of miRNAs has been detected in various cancers. For example, miR-15a/16-1 could attenuate immunosuppression and represent a potential immunotherapy against hepatocellular carcinoma [
14], meanwhile, miR-124-3p could promote cell proliferation in intrahepatic cholangiocarcinoma [
15]. Additionally, by modulating STAT3 signaling, miR-124-3p was identified to suppress programmed cell death-ligand 1 (PD-L1) expression and inhibit tumorigenesis of colorectal cancer [
16]. Nevertheless, as a highly aggressive cancer, studies exploring the potential roles of invasion-metastasis associated miRNAs in GBC are limited.
In the study, we aimed to conduct bioinformatic analysis to identify the invasion-metastasis associated miRNAs in GBC, and experimental validation were further performed to confirm the role of miRNAs. In turn, the study would provide potential effective treatment for improving the prognosis of GBC patients.
Methods
Data collection
Datasets of miRNA expression of GBC tissues with survival data from the National Center for Biotechnology Information (NCBI) (
https://www.ncbi.nlm.nih.gov/geo) online Gene Expression Omnibus (GEO) database were included in the study. The search strategy was “gallbladder cancer” [MeSH Terms] AND “miRNA” [MeSH Terms]. After screening the datasets, the GSE104165 dataset, which contained 40 human GBC tumor samples and 8 normal gallbladder samples with survival data, was selected for further analysis. The sample platform was GPL18402 Agilent-046064 Unrestricted_Human_miRNA_V19.0_Microarray.
Screening miRNAs of different expression
The miRNA expression data profile in txt format were preprocessed. Limma package was applied to calculate the miRNA of different expression from the Bioconductor package (
http://www.bioconductor.org/). MiRNAs of different expression were found by comparing GBC tumor samples with long survival and short survival in R Studio (Version 4.0.4). Different expression was determined as significant when
P-value < 0.05 and |fold change (FC)|> 1.
Target genes prediction and gene ontology (GO) analysis
MiRTarBase (
http://mirtarbase.mbc.nctu.edu.tw/php/index.php), an online miRNA-target interactions database, was used for identifying the potential target genes of the up-regulated or down-regulated miRNAs. The data were further validated by microarray, western blot, reporter assay, and next-generation sequencing experiments. GO analysis was extensively used for the determination of unique biological attributes of genes, gene products, and sequences, such as molecular function, cell components, and biological process [
17]. Enrichr (
http://amp.pharm.mssm.edu/Enrichr/), a 2016 updated webserver with a comprehensive enrichment analysis of the gene set, was introduced to manipulate enrichment analysis of the predicted target genes pathway and functional annotation, which was further analyzed for GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways [
18].
MiRNA-gene and protein–protein interaction (PPI) network construction
Tools were used to determine the interactions between genes or proteins to establish the miRNA-gene and PPI network. The target genes were first entered to assess functional associations in the STRING database (
http://string-db.org) [
19]. Next, the connectivity degree of PPI network was calculated in Cytoscape software (Version 3.6.0) for further hub genes evaluation. Finally, a miRNA-hub gene regulatory network was generated.
The cancer genome atlas (TCGA) database and survival data of GBC patients
The BTC miRNA-sequencing data and clinical information were retrieved from TCGA database (
https://portal.gdc.cancer.gov) to explore miR-642a-3p and miR-145-5p expression levels in BTC tissues. The data of overall survival (OS) were matched with miR-642a-3p and miR-145-5p expression values. A total of 41 GBC specimens were randomly selected from curative resection GBC patients retrospectively in Sir Run-Run Shaw Hospital (SRRSH), Hangzhou, Zhejiang Province, China. The interval between surgery and death was defined as OS. The follow-up period was defined as the duration between surgery and recurrence or death. The final follow-up was in December 2019.
Validation of potential target genes using TCGA database
Based on short and long survival of GBC patients in TCGA database, the related mRNA expression (SYK, SH3GL1, CDKN1A, MYC, VEGFA, and EGFR) were compared between two groups. Moreover, the expression of some potential mRNA (CDKN1A, MYC, VEGFA) was further compared based on different T stages, which represented tumor invasion.
Cell culture and tissue collection
Human GBC cell line GBC-SD and human intrahepatic biliary epithelial cells (HiBEC) were purchased from a cell bank (Chinese Academy of Sciences). The SGC-996 cell line was provided by Prof. Anonymize (Blinded Per Author Guidelines). The GBC-SD and SGC-996 cells were given 25 units/ml of penicillin, 25 g/ml of streptomycin, and 10% fetal bovine serum (FBS) (v/v) in a 5% (v/v) CO2 humidified incubator at 37 °C, and they were cultivated in DMEM and RPMI-1640, respectively. Our hospital provided the GBC tumor tissues and matched noncancerous tissues.
RNA extraction and quantitative real-time PCR (qRT-PCR)
TRIzol reagent (Ambion, USA) was used to extract total RNA from cells, and miRNeasy FFPE kits (Qiagen, USA) were used to isolate the FFPE tissues based on the manufacturer’s protocols. All-in-One™ miRNA qRT-PCR Detection Kit (GeneCopoeia, USA) or Hifair® II 1st Strand cDNA Synthesis SuperMix (Yeasen, China) were used to make complementary DNA from 1 μg of RNA. qRT-PCR was performed using a LightCycler® 480 (Roche Molecular Systems, Inc., USA). The primers used for miRNA qRT-PCR were shown in Additional file
1: Table S1, and 5s small nuclear RNA was the miRNA assays internal control. Based on the cycle thresholds (CT), qRT-PCR results were examined and calculated as the relative RNA levels. The FC in RNA levels between each sample was examined by the 2
−ΔΔCT method.
Cell transfection
Hsa-miRNA mimics and cognate negative control RNAs were obtained from RiBo (Guangzhou, China) and transfected into GBC cell lines at the concentration of 50 nM using Lipofectamine™ 3000 (Invitrogen, USA) based on the user instructions.
Wound healing assay and transwell assay
After transfection, 5 × 104 GBC cells were seeded in ibidi Culture-Insert (ibidi GmbH, Martinsried, Germany) on a 12-well plate. The Culture-Insert was gently removed after appropriate cell attachment. Then the cells could migrate into the wound area. Photomicrographs were taken with a microscope at 0 h and 48 h after wounding, respectively. The cell invasion assay was performed by 24-well Transwell chambers (Corning, USA). Next, 1 × 105 cells were evenly suspended in a 200 µl serum-free medium and added to the up-layer inserts after transfection. 600 µl of medium with 20% FBS was then added to the low-layer compartment for chemoattractant. The cells on the membrane top surface were excised using a cotton-wool bud, whereas the cells on the bottom surface were fixed with 4% paraformaldehyde and stained with 0.1% crystal violet after 24-h incubation. Five random visual fields in each chamber were captured and counted under a microscope (Zeiss, German).
Immunohistochemistry (IHC)
IHC was further conducted to indirectly validate the potential target genes expression of miR-642a-3p and miR-145-5p. Briefly, 4-μm sections from tissue blocks of the included GBC patients in our hospital were taken on coated slides. Then the slides were deparaffinized, hydrated, and blocked with hydrogen peroxide. The appropriate buffer for each antibody was utilized for heat induced antigen retrieval. The slides were incubated with primary antibody, following with secondary antibody (anti-SYK antibody, anti-SH3GL1 antibody, anti-CDKN1A antibody, anti-MYC antibody, anti-VEGFA antibody, anti-EGFR antibody). Diaminobenzidine (DAB) chromogen and haematoxylin were used for staining and counterstaining, respectively.
Statistical analysis
Unpaired tailed student’s t tests, Kaplan–Meier survival analysis, and log-rank tests were used for statistical analyses with GraphPad Prism 8 (GraphPad Software, Inc., La Jolla, CA, USA). The results were shown as mean ± standard deviation (SD). P < 0.05 was considered statistically significant.
Discussion
In the study, miR-642a-3p and miR-145-5p were identified as invasion-metastasis associated miRNAs according to the bioinformatic analysis and experimental validation. As both two miRNAs were crucial in GBC invasion and metastasis, they would be utilized as promising targets for effective treatment to improve the prognosis of GBC patients.
Currently, miRNAs were gradually considered as essential regulators for tumor initiation, promotion, and progression transcriptional dynamics in GBC [
26,
27], and thus researchers should pay more attention to systemically analyzing the invasion-metastasis associated miRNA in GBC. MiR-7-2-3p and miR-29c-3p were identified as metastasis suppressors for GBC via high-throughput screening, and they were also related to the pathogenesis of GBC [
28]. Meanwhile, Ma et al
. [
29] demonstrated that miR-663a could regulate epithelial membrane protein-3 to suppresses GBC progression via interfering the MAPK/ERK pathway, indicating that the miR-663a/EMP3/MAPK/ERK axis would be potential treatment for GBC. Besides, after being activated by TGF-β1, miR-20a could play a crucial role in the pathogenesis and trigger metastasis of GBC through the miR-20a/Smad7/β-catenin axis [
26]. Despite the identified miRNAs, further studies would be performed to offer more insights into improving the prognosis of GBC.
Indeed, a total of 4 miRNAs, including the top 2 up-regulated miRNAs (miR-642a-3p and miR-4430) and the top 2 down-regulated miRNAs (miR-145-5p and miR-451a), were selected for experimental validation. It was shown that miR-145-5p up-regulation and miR-642a-3p down-regulation regulated cell invasion and migration in GBC. Interestingly, the decrease in miR-4430 expression suppressed cell invasion and wound healing migration to enhance GBC loss-of-function, in the meantime, up-regulation of miR-451a significantly suppressed the invasion (Additional file
1: Fig. S6). Similar to our results, Ueta et al
. [
30] found that serum EVs miR-451a were significantly down-regulated and miR-451a inhibited GBC cell proliferation and induced apoptosis. Taken together, miR-451a would also be a novel therapeutic target for GBC patients.
In the miRNA-gene hub network, the hub genes were potentially regulated by miR-145-5p and miR-642a-3p. Various studies demonstrated that miR-145-5p was linked with various types of cancer, such as hepatocellular carcinoma [
31], gastric cancer [
32,
33], and upper tract urothelial carcinoma [
34]. MiR-642a-3p was also linked to cell migration and invasion of hepatocellular carcinoma [
35]. Besides, miR-29c-3p was found to be down-regulated (Table
2), which was in accordance with the results that up-regulation of miR-29c-3p could reverse EMT and decrease the metastasis ability in vitro and in vivo [
28]. Similar to our results in Table
2, Jin et al
. [
36] also found that miR-143-3p suppressed tumor angiogenesis and growth of GBC through the ITGA6/PI3K/AKT/PLGF pathways. The aberrant expression of miRNAs have been relevant to GBC tumorigenesis and progression.
qRT-PCR results indicated that miR-145-5p and miR-642a-3p were significantly up- and down-regulated among GBC cell lines and clinical samples, respectively. MiR-145-5p up-regulation and miR-642a-3p down-regulation could significantly suppress in vitro activation, migration, and invasion of GBC using wound-healing and Transwell invasion assay. To explore the possible pathways, we performed GO annotation and KEGG pathway analysis for the predicted target genes of the top 2 most up- and down-regulated miRNAs using the Enrichr tool. Several target genes were revealed to be enriched in cell–cell adhesion, which was closely correlated to cell migration and invasion. Therefore, it would be a promising mechanism that can relieve the impacts of miR-145-5p and miR-642a-3p for GBC by targeting these genes.
The study has several limitations that need to be addressed. First, the public dataset with both miRNA and mRNA profiling in GBC was limited. Therefore, we tried to validate our results using different GBC databases (TCGA and SRRSH databases). Unfortunately, some verification results would not be obvious because of the small sample size. And further validation experiments should be performed with a large sample size. Second, merely 2 most up- and down-regulated miRNAs and the relevant target genes were included in the enrichment analysis. Further studies would be focused on more miRNAs of different expression to explore more potential treatment for GBC. Third, we selected 2 up- and down-regulated miRNAs for in vitro experiment validation, which would lead to the omittance of some functional miRNAs. And in vitro and in vivo experiments should be performed to reveal other functional miRNAs with a high validation accuracy. Finally, the deeper molecular mechanisms of GBC invasion and metastasis should also be explored in the future.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.